Daily Care for May 19, 2021
advertisement
- CGM offers more benefits than burdens for parents of children with type 1 diabetes
- Advanced glycation end products as predictors of renal function in youth with type 1 diabetes
- Type 1 diabetes left out of Covid-19 conversation, but ripple effects are ongoing
- “Hyperglycemia aversiveness”: Investigating an overlooked problem among adults with type 1 diabetes (HTML)
- The changing incidence of childhood-onset type 1 diabetes in Wales: Effect of gender and season at diagnosis and birth
- Continuous ketone monitoring may provide early identification of DKA
- Barriers to Technology Use and Endocrinology Care for Underserved Communities With Type 1 Diabetes
- Magnitude and Determinants of Diabetic Retinopathy Among Indian Diabetic Patients Undergoing Telescreening in India
- Decreasing Prevalence of Retinopathy in Childhood-Onset type 1 Diabetes over the Last decade. A Comparison of two Cohorts Diagnosed Ten Years Apart (HTML)
- A Real-World Study of User Characteristics, Safety and Efficacy of Open-Source Closed-Loop Systems and Medtronic 670G (HTML)
- Exercise Effect on Insulin-Dependent and Insulin-Independent Glucose Utilization in Healthy and Type 1 Diabetes Individuals. A Modeling Study (HTML)
- Benefits and Challenges of Current Closed-Loop Technologies in Children and Young People With Type 1 Diabetes (HTML)
- Ramadan fasting and diabetes, latest evidence and technological advancements: 2021 update (HTML)
- Fear of hypoglycemia, a game changer during physical activity in type 1 diabetes mellitus patients (HTML)
- Classification of Gastroparesis from Glycemic Variability in Type 1 Diabetes: A Proof-of-Concept Study (HTML)
- Disparities in Utilization and Outcomes with Continuous Subcutaneous Insulin Infusion in Young Adults with T1D (HTML)
- Advances, Challenges, and Cost Associated with Continuous Glucose Monitor Use in Adolescents and Young Adults with Type 1 Diabetes (HTML)
- Frequency of Autoantibody-Negative Type 1 Diabetes in Children, Adolescents, and Young Adults During the First Wave of the COVID-19 Pandemic in Germany (HTML)
- Reductions in Management Distress Following a Randomized Distress Intervention Are Associated With Improved Diabetes Behavioral and Glycemic Outcomes Over Time (HTML)
- Should continuous glucose monitoring systems be offered to all patients with type 1 diabetes mellitus? (HTML)
- “I’ve Had an Alarm Set for 3:00 a.m. for Decades”: The Impact of Type 1 Diabetes on Sleep
- Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study pro (HTML)
